Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026)
Nurix Therapeutics' (NRIX) Asset Utilization Ratio came in at 0.06 for fiscal Q2 2026 (quarter ended May 31, 2026), down 57.2% from 0.15 a year earlier and down 42.1% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Asset Utilization Ratio stood at 0.12, up 16.2% from FY2024.
- In prior fiscal years, Nurix Therapeutics' Asset Utilization Ratio was 0.11 in FY2024 (-46.6%), 0.20 in FY2023 (+130.6%), 0.09 in FY2022 (+26.9%) and 0.07 in FY2021 (-15.8%).
- The fiscal Q2 2026 figure stands as the lowest quarterly Asset Utilization Ratio since fiscal Q4 2021.
- On a year-over-year basis, Asset Utilization Ratio increased in three of the last eight quarters, with an average decline of 15.1%.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was fiscal Q4 2023, with growth of 163.1%; the weakest was fiscal Q1 2025, with a decline of 63.7%.
- According to Business Quant data, Asset Utilization Ratio for the three prior fiscal quarters was 0.11 (Q1 2026), 0.14 (Q4 2025) and 0.15 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | 0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.06 |
| Feb 28, 2026 | 0.11 |
| Nov 30, 2025 | 0.14 |
| Aug 31, 2025 | 0.15 |
| May 31, 2025 | 0.15 |
| Feb 28, 2025 | 0.09 |
| Nov 30, 2024 | 0.09 |
| Aug 31, 2024 | 0.11 |
| May 31, 2024 | 0.15 |
| Feb 29, 2024 | 0.24 |
| Nov 30, 2023 | 0.23 |
| Aug 31, 2023 | 0.21 |
| May 31, 2023 | 0.17 |
| Feb 28, 2023 | 0.11 |
| Nov 30, 2022 | 0.09 |
| Aug 31, 2022 | 0.09 |
| May 31, 2022 | 0.09 |
| Feb 28, 2022 | 0.08 |
| Nov 30, 2021 | 0.06 |
| Aug 31, 2021 | 0.06 |
API Access
Nurix Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();